A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis

NCT00246259 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder
Schizophreniform Disorder
Psychotic Disorders

Interventions

DRUG: Risperidone long-acting injection (LAI)
DRUG: Oral Antipsychotic

Sponsor

Janssen-Ortho Inc., Canada